Expertise Across Diagnostic Development and Production
EXIMIO brings together diagnostic raw materials, biomaterial development, lateral flow technology and production-oriented experience to support IVD projects beyond individual reagent supply.
Our technical perspective is built around how antibodies, antigens, functional materials, assay conditions and manufacturing processes interact within a complete diagnostic system.
Antibodies, antigens and related biomaterials for IVD development.
Customized antibody and antigen development for specific projects.
Material evaluation, assay optimization and technical troubleshooting.
Practical consideration of process transfer and downstream manufacturing.
More Than a Single Technical Discipline
Diagnostic performance depends on multiple technical elements working together. Our expertise spans the materials, assay development and production considerations that influence the transition from an early concept to a repeatable diagnostic product.
Diagnostic Raw Materials
We work with antibodies, antigens and related IVD raw materials with attention to their intended assay application rather than treating each material only as an isolated reagent.
Antibody & Antigen Development
For projects that require dedicated biomaterials, customized development can support more specific target, application and long-term supply requirements.
Lateral Flow Development
Our lateral flow experience covers material selection, pairing, optimization, troubleshooting and the practical interaction between reagents and functional components.
Manufacturing & Scale-Up
Development decisions are considered together with process reproducibility, manufacturing workflow and downstream production requirements where appropriate.
Understanding the Assay as a Complete System
Lateral flow performance is determined by more than an antibody pair. Membranes, conjugates, pads, buffers, dispensing conditions and production parameters can all influence the final result.
Material Selection
Evaluate antibodies, antigens, membranes, conjugate materials and other functional components according to the intended assay.
Reagent Pair Evaluation
Compare candidate capture and detection combinations and assess their suitability for further assay development.
Assay Optimization
Review concentrations, conjugation, buffers, flow conditions and other parameters that affect assay behavior.
Performance Troubleshooting
Investigate sensitivity, specificity, background, flow, reproducibility and other development challenges.
Process Transfer
Consider how optimized laboratory conditions can be translated into more controlled downstream manufacturing parameters.
Building Reagents Around the Application
When standard materials do not fully match a project requirement, dedicated antibody or antigen development can provide another route toward an application-specific solution.
Custom Antibody Development
Development can be discussed for projects requiring dedicated monoclonal or polyclonal antibodies according to target and application requirements.
Custom Antigen Development
Antigen development can be considered according to target biology, intended use and the technical requirements of downstream diagnostic evaluation.
Screening & Characterization
Candidate biomaterials can be evaluated using project-relevant screening and characterization approaches before further assay development.
Technical Decisions Should Survive Scale-Up
A result that works during laboratory development must ultimately remain practical under more controlled production conditions. Our production-oriented experience helps us consider downstream requirements earlier in the technical process.
Select materials with the intended assay and downstream use in mind.
Establish workable reagent combinations and operating conditions.
Identify critical parameters that influence repeatability and process control.
Move toward more reproducible pilot or routine manufacturing conditions.
Why We Connect Materials, Assays and Production
Technical problems are often caused by interactions between multiple parts of the diagnostic system rather than by one individual reagent alone.
Better Material Decisions
Material selection can be considered in the context of the intended assay rather than only from isolated reagent data.
More Practical Troubleshooting
Performance issues can be reviewed across reagents, functional components, assay conditions and process variables.
Clearer Path Toward Production
Manufacturing considerations can be introduced before the project reaches the final stage of laboratory development.
Capabilities That Support Technical Development
Depending on project requirements, supporting laboratory and manufacturing capabilities can be incorporated into the development process.
BLI Affinity Evaluation
Real-time, label-free molecular interaction analysis for relevant antigen-antibody characterization and comparison.
Paired Antibody Screening
Evaluation of candidate capture and detection combinations for sandwich-format diagnostic applications.
Stable Production Strategy
Relevant projects can consider antibody sequence and stable production approaches where long-term reagent consistency is important.
Uncut Sheet OEM
Production-oriented support for suitable rapid diagnostic projects progressing toward downstream manufacturing.
Bring us your diagnostic development challenge
Whether you are evaluating a raw material, developing a lateral flow assay or planning for downstream production, our team can discuss the technical requirements of your project.